IC
LBPH

Ikarian Capital’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Ikarian Capital’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-236
Closed -$5.1K – 163
2024
Q1 		$5.1K Sell
236
-979,226
-100% -$21.4M ﹤0.01% 137
2023
Q4 		$5.91M Buy
979,462
+465,361
+91% +$2.32M 0.55% 57
2023
Q3 		$2.86M Buy
514,101
+9,848
+2% +$63.4K 0.34% 67
2023
Q2 		$3.7M Buy
+504,253
New +$3.82M 0.59% 48

Other funds holding LBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Ikarian Capital's LBPH Position: Q2 2024 in Review

Ikarian Capital sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2024, closing a stake of 236 shares — an estimated $5.1K sold.

Ikarian Capital first reported a position in LBPH in Q2 2023 and held it in 4 quarters. The position peaked at $5.91M in Q4 2023. 100 funds tracked by Wall St. Rank hold LBPH as of Q2 2024.

  • Ikarian Capital reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ikarian Capital sold 236 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $5.1K.
  • Ikarian Capital first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Ikarian Capital's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $5.91M in Q4 2023.
  • 100 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Ikarian Capital's 13F filing for Q2 2024, filed 14 Aug 2024.